Self-Reported Adherence to Cholesterol-Lowering Medication in Patients with Familial Hypercholesterolaemia: The Role of Illness Perceptions

SummaryBackground: The objectives of this study are to describe levels of adherence to cholesterol-lowering medication and to identify predictors of adherence in patients with familial hypercholesterolaemia (FH). Design: Descriptive questionnaire study. Methods:: 336 adults patients with FH attending one of five outpatient lipid clinics in South East England underwent a clinical assessment by a nurse and completed a questionnaire. The questionnaire assessed self-reported adherence to cholesterol-lowering medication, anxiety, depression, and patient perceptions of heart disease. Results:: Overall, participants reported high levels of medication adherence, although 63% reported some level of non-adherence. Total medication adherence (never deviating from the regimen) was more likely to be reported by older participants, those with no formal educational qualifications, those with a personal history of cardiovascular disease, those with a lower total cholesterol level, and those with a greater difference between untreated cholesterol levels and current cholesterol levels. The illness perceptions associated with reported total adherence were lower perceived risk of raised cholesterol, perceiving greater control over FH, and perceiving genes and cholesterol to be important determinants of a heart attack. Emotional state was not associated with medication adherence. In logistic regression analysis, predictors of total medication adherence were having personal history of cardiovascular disease, having no formal qualifications, and perceiving genes to be important determinants of a heart attack. Conclusions: Both clinical factors and patients’ illness perceptions were associated with self-reported cholesterol-lowering medication adherence. The association with illness perceptions was small and many of these associations may be a consequence, rather than a cause, of greater adherence. Given this, intervention strategies aimed at helping patients’ to establish routines for medication taking may be more effective in increasing adherence than interventions designed to alter perceptions related to taking statins.

[1]  P. Sheeran,et al.  Implementation intentions and repeated behaviour: augmenting the predictive validity of the theory of planned behaviour , 1999 .

[2]  J. Kastelein,et al.  Long-term compliance with lipid-lowering medication after genetic screening for familial hypercholesterolemia. , 2003, Archives of internal medicine.

[3]  Keith Petrie,et al.  The Revised Illness Perception Questionnaire (IPQ-R) , 2002 .

[4]  W. Insull.  The problem of compliance to cholesterol altering therapy , 1997, Journal of internal medicine.

[5]  Peter W. Macfarlane,et al.  Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia , 2004 .

[6]  J. Weinman,et al.  Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. , 1999, Journal of psychosomatic research.

[7]  T. Marteau,et al.  The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). , 1992, The British journal of clinical psychology.

[8]  M. Eriksson,et al.  Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care. , 1997, Journal of internal medicine.

[9]  B. Sivertsen,et al.  The Revised Illness Perception Questionnaire (IPQ-R) , 2004 .

[10]  P. Sheeran.  Intention—Behavior Relations: A Conceptual and Empirical Review , 2002 .

[11]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.

[12]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, East African medical journal.

[13]  M. Dimatteo,et al.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. , 2000, Archives of internal medicine.

[14]  J. Avorn,et al.  Persistence of use of lipid-lowering medications: a cross-national study. , 1998, JAMA.

[15]  R. Snaith,et al.  The hospital anxiety and depression scale. , 2013, Acta psychiatrica Scandinavica.

[16]  S. Humphries,et al.  Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: A randomized controlled trial , 2004, American journal of medical genetics. Part A.

[17]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[18]  Keith J. Petrie,et al.  Perceptions of Health and Illness: Current Research and Applications. Edited by K. J. Petrie and J. A. Weinman. Harwood Academic Publishers: New York. 1998. , 1999, Psychological Medicine.

[19]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[20]  H. Leventhal,et al.  Common-sense models of illness: the example of hypertension. , 1985, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[21]  P. Giral,et al.  Factors associated with low compliance with lipid‐lowering drugs in hyperlipidemic patients , 2000, Journal of clinical pharmacy and therapeutics.